SG11201610456UA - Influenza virus vaccines and uses thereof - Google Patents
Influenza virus vaccines and uses thereofInfo
- Publication number
- SG11201610456UA SG11201610456UA SG11201610456UA SG11201610456UA SG11201610456UA SG 11201610456U A SG11201610456U A SG 11201610456UA SG 11201610456U A SG11201610456U A SG 11201610456UA SG 11201610456U A SG11201610456U A SG 11201610456UA SG 11201610456U A SG11201610456U A SG 11201610456UA
- Authority
- SG
- Singapore
- Prior art keywords
- influenza virus
- virus vaccines
- vaccines
- influenza
- virus
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/145—Orthomyxoviridae, e.g. influenza virus
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- C07K14/08—RNA viruses
- C07K14/11—Orthomyxoviridae, e.g. influenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16123—Virus like particles [VLP]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Communicable Diseases (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP14176459 | 2014-07-10 | ||
| US201462062754P | 2014-10-10 | 2014-10-10 | |
| EP14195143 | 2014-11-27 | ||
| EP15155761 | 2015-02-19 | ||
| PCT/EP2015/065663 WO2016005482A1 (en) | 2014-07-10 | 2015-07-09 | Influenza virus vaccines and uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201610456UA true SG11201610456UA (en) | 2017-01-27 |
Family
ID=55063616
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201610456UA SG11201610456UA (en) | 2014-07-10 | 2015-07-09 | Influenza virus vaccines and uses thereof |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US10117925B2 (zh) |
| EP (1) | EP3166963B1 (zh) |
| JP (1) | JP7094103B2 (zh) |
| KR (1) | KR102463632B1 (zh) |
| CN (1) | CN107074912B (zh) |
| AU (1) | AU2015286723B2 (zh) |
| BR (1) | BR112016030577A8 (zh) |
| CA (1) | CA2953451C (zh) |
| CL (1) | CL2017000064A1 (zh) |
| EA (1) | EA035375B1 (zh) |
| MX (1) | MX2017000395A (zh) |
| MY (1) | MY182440A (zh) |
| PE (1) | PE20170291A1 (zh) |
| PH (1) | PH12016502468A1 (zh) |
| SG (1) | SG11201610456UA (zh) |
| WO (1) | WO2016005482A1 (zh) |
| ZA (1) | ZA201700165B (zh) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2787099A1 (en) | 2009-03-30 | 2010-10-14 | Anice C. Lowen | Influenza virus hemagglutinin polypeptides containing stem domains, vaccines and uses thereof |
| AU2012343981B2 (en) | 2011-11-28 | 2017-09-07 | Janssen Vaccines & Prevention B.V. | Influenza virus vaccines and uses thereof |
| US9968670B2 (en) | 2012-12-18 | 2018-05-15 | Icahn School Of Medicine At Mount Sinai | Influenza virus vaccines and uses thereof |
| WO2014159960A1 (en) | 2013-03-14 | 2014-10-02 | Icahn School Of Medicine At Mount Sinai | Antibodies against influenza virus hemagglutinin and uses thereof |
| JP6643981B2 (ja) | 2013-05-30 | 2020-02-12 | ヤンセン ファッシンズ アンド プリベンション ベーフェーＪａｎｓｓｅｎ Ｖａｃｃｉｎｅｓ ＆ Ｐｒｅｖｅｎｔｉｏｎ Ｂ．Ｖ． | インフルエンザウイルスワクチンおよびその使用 |
| MX2017000394A (es) | 2014-07-10 | 2017-11-30 | Janssen Vaccines & Prevention Bv | Vacunas para virus influenza y usos de las mismas. |
| EP3247389A4 (en) | 2015-01-23 | 2019-10-30 | Icahn School of Medicine at Mount Sinai | INFLUENZAVIRUSSCHUTZIMPFPLÄNE |
| JP7237344B2 (ja) | 2016-06-15 | 2023-03-13 | アイカーン スクール オブ メディシン アット マウント サイナイ | インフルエンザウイルス血球凝集素タンパク質及びその使用 |
| CN118146389A (zh) | 2016-09-02 | 2024-06-07 | 美国卫生与公众服务部 | 稳定化的第2组流感血凝素茎区三聚体及其用途 |
| WO2018187706A2 (en) | 2017-04-07 | 2018-10-11 | Icahn School Of Medicine At Mount Sinai | Anti-influenza b virus neuraminidase antibodies and uses thereof |
| CN107765001B (zh) * | 2017-10-24 | 2020-03-27 | 中国科学院苏州纳米技术与纳米仿生研究所 | 禽流感病毒感染或禽流感疫苗免疫分型试剂盒 |
| LT3743106T (lt) | 2018-01-23 | 2022-09-26 | Janssen Vaccines & Prevention B.V. | Gripo viruso vakcinos ir jų panaudojimo būdai |
| JP7329529B2 (ja) * | 2018-03-28 | 2023-08-18 | サノフィ パスツール インコーポレイテッド | ヘマグルチニンを含む広範に防御的なワクチン組成物を生成する方法 |
| MX2020013961A (es) * | 2018-06-27 | 2021-03-09 | Medicago Inc | Mutantes de hemaglutinina del virus de la influenza. |
| CN109239355B (zh) * | 2018-09-05 | 2020-08-25 | 中牧实业股份有限公司 | 禽流感病毒h9亚型抗体酶联免疫检测试剂盒 |
| US12064478B2 (en) | 2018-09-21 | 2024-08-20 | Nutech Ventures | Methods of making and using universal centralized influenza vaccine genes |
| CN114430742A (zh) * | 2019-09-05 | 2022-05-03 | 扬森疫苗与预防公司 | 流感病毒疫苗及其用途 |
| GB202004825D0 (en) * | 2020-04-01 | 2020-05-13 | Diosynvax Ltd | Influenza vaccines |
| MX2023002674A (es) * | 2020-09-07 | 2023-04-03 | Intervet Int Bv | Vacuna del tallo de ha para blancos positivos a anticuerpos ha. |
| WO2022269343A1 (en) * | 2021-06-23 | 2022-12-29 | Ruenhuei Biopharmaceuticals Inc. | Multivalent vaccine for protection against multiple virus infection |
| WO2023154821A2 (en) * | 2022-02-11 | 2023-08-17 | University Of Washington | Compositions comprising influenza hemagglutinin stem and method for enhancing cross-protective immunity |
| WO2023198815A1 (en) | 2022-04-14 | 2023-10-19 | Janssen Vaccines & Prevention B.V. | Sequential administration of adenoviruses |
| WO2024104947A2 (en) * | 2022-11-14 | 2024-05-23 | Janssen Vaccines & Prevention B.V. | Influenza b virus vaccines and uses thereof |
| CN116589566A (zh) * | 2022-11-18 | 2023-08-15 | 昆明医科大学第一附属医院 | 一种HIV-1中和抗体的改造重组单克隆IgM抗体及其应用 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2059532B1 (en) | 2006-09-07 | 2012-12-26 | Crucell Holland B.V. | Human binding molecules capable of neutralizing influenza virus h5n1 and uses thereof |
| CA2787099A1 (en) * | 2009-03-30 | 2010-10-14 | Anice C. Lowen | Influenza virus hemagglutinin polypeptides containing stem domains, vaccines and uses thereof |
| NZ596032A (en) | 2009-05-11 | 2013-09-27 | Crucell Holland Bv | Human binding molecules capable of neutralizing influenza virus h3n2 and uses thereof |
| EP3248615A1 (en) * | 2010-03-30 | 2017-11-29 | Mount Sinai School of Medicine of New York University | Influenza virus vaccines and uses thereof |
| US8900585B2 (en) * | 2010-10-20 | 2014-12-02 | New York Blood Center, Inc. | Influenza hemagglutinin-specific monoclonal antibodies for preventing and treating influenza virus infection |
| EP2731967B1 (en) | 2011-07-14 | 2016-10-12 | Janssen Vaccines & Prevention B.V. | Human binding molecules capable of neutralizing influenza a viruses of phylogenetic group 1 and phylogenetic group 2 and influenza b viruses |
| AU2012343981B2 (en) | 2011-11-28 | 2017-09-07 | Janssen Vaccines & Prevention B.V. | Influenza virus vaccines and uses thereof |
| JP6643981B2 (ja) | 2013-05-30 | 2020-02-12 | ヤンセン ファッシンズ アンド プリベンション ベーフェーＪａｎｓｓｅｎ Ｖａｃｃｉｎｅｓ ＆ Ｐｒｅｖｅｎｔｉｏｎ Ｂ．Ｖ． | インフルエンザウイルスワクチンおよびその使用 |
| MX2017000394A (es) | 2014-07-10 | 2017-11-30 | Janssen Vaccines & Prevention Bv | Vacunas para virus influenza y usos de las mismas. |
-
2015
- 2015-07-09 BR BR112016030577A patent/BR112016030577A8/pt not_active Application Discontinuation
- 2015-07-09 CN CN201580037387.0A patent/CN107074912B/zh active Active
- 2015-07-09 WO PCT/EP2015/065663 patent/WO2016005482A1/en active Application Filing
- 2015-07-09 MX MX2017000395A patent/MX2017000395A/es unknown
- 2015-07-09 SG SG11201610456UA patent/SG11201610456UA/en unknown
- 2015-07-09 KR KR1020177003528A patent/KR102463632B1/ko active IP Right Grant
- 2015-07-09 JP JP2017500875A patent/JP7094103B2/ja active Active
- 2015-07-09 PE PE2017000043A patent/PE20170291A1/es unknown
- 2015-07-09 AU AU2015286723A patent/AU2015286723B2/en active Active
- 2015-07-09 CA CA2953451A patent/CA2953451C/en active Active
- 2015-07-09 EP EP15738028.8A patent/EP3166963B1/en active Active
- 2015-07-09 US US15/324,939 patent/US10117925B2/en active Active
- 2015-07-09 EA EA201692467A patent/EA035375B1/ru not_active IP Right Cessation
- 2015-07-09 MY MYPI2017700047A patent/MY182440A/en unknown
-
2016
- 2016-12-12 PH PH12016502468A patent/PH12016502468A1/en unknown
-
2017
- 2017-01-09 ZA ZA2017/00165A patent/ZA201700165B/en unknown
- 2017-01-10 CL CL2017000064A patent/CL2017000064A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2953451C (en) | 2023-09-19 |
| CN107074912B (zh) | 2021-10-29 |
| WO2016005482A1 (en) | 2016-01-14 |
| US20170189519A1 (en) | 2017-07-06 |
| BR112016030577A2 (pt) | 2017-10-31 |
| EA201692467A1 (ru) | 2017-05-31 |
| PH12016502468B1 (en) | 2017-04-10 |
| AU2015286723B2 (en) | 2019-11-21 |
| CA2953451A1 (en) | 2016-01-14 |
| CN107074912A (zh) | 2017-08-18 |
| KR102463632B1 (ko) | 2022-11-03 |
| AU2015286723A1 (en) | 2017-01-12 |
| JP2017521073A (ja) | 2017-08-03 |
| MX2017000395A (es) | 2018-02-08 |
| PH12016502468A1 (en) | 2017-04-10 |
| KR20170027846A (ko) | 2017-03-10 |
| ZA201700165B (en) | 2019-06-26 |
| MY182440A (en) | 2021-01-25 |
| US10117925B2 (en) | 2018-11-06 |
| JP7094103B2 (ja) | 2022-07-01 |
| EA035375B1 (ru) | 2020-06-03 |
| BR112016030577A8 (pt) | 2021-07-20 |
| EP3166963B1 (en) | 2020-04-22 |
| EP3166963A1 (en) | 2017-05-17 |
| PE20170291A1 (es) | 2017-03-26 |
| CL2017000064A1 (es) | 2017-11-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA201700165B (en) | Influenza virus vaccines and uses thereof | |
| HK1255847A1 (zh) | 針對乙型肝炎病毒的疫苗 | |
| SG10201913630YA (en) | Zika virus vaccine | |
| SI3718565T1 (sl) | Cepiva za respiratorni virus | |
| HK1246183A1 (zh) | Hpv疫苗 | |
| HUE061679T2 (hu) | Zika vírus vakcina | |
| ZA201700952B (en) | Indoles for use in influenza virus infection | |
| IL286265A (en) | A new tilapia virus and its uses | |
| HK1223110A1 (zh) | 流行性感冒病毒疫苗及其用途 | |
| SG11201610443WA (en) | Influenza virus vaccines and uses thereof | |
| EP3119883A4 (en) | Influenza virus vectors and uses therefor | |
| GB201613191D0 (en) | Zika virus vaccine | |
| HK1254344A1 (zh) | 抗原匹配的流感疫苗 | |
| SG11201702116VA (en) | Viral rna segments as immunomodulatory agents and vaccine components | |
| IL247185A0 (en) | Tilapia virus vaccines | |
| SG11201701279VA (en) | Alkylated influenza vaccines | |
| EP3240568A4 (en) | Recombinant influenza virus vaccines for influenza and respiratory syncytial virus | |
| EP3157950A4 (en) | Influenza vaccines and methods of use thereof | |
| IL249705B (en) | Influenza virus vaccines and their uses | |
| IL249704A0 (en) | Influenza virus vaccines and their uses | |
| PT3393510T (pt) | Vacina contra o vírus zika | |
| TH1501007185A (th) | ไวรัสและวัคซีน | |
| GB201408046D0 (en) | Virus preparations |